The Latest Cardiac and Vascular News
VANCOUVER and MINNEAPOLIS, Feb. 20, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc, Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN), a leader in the development of minimally invasive transcatheter mitral valve replacement technologies and in the development of minimally invasive devices for the treatment of refractory angina, today announced that it will […]
Novoheart Among Top 10 TSX-V Performers in Clean Technology & Life Sciences Sector Ranking based on share price increase, trading volume and market capitalization VANCOUVER, British Columbia, Feb. 20, 2020 (GLOBE NEWSWIRE) — Novoheart (“Novoheart” or the “Company”) (TSXV: NVH; FWB: 3NH), a global stem cell biotechnology company, is pleased to announce […]
Fourth Quarter 2019 Revenues of $681.0 million, up 6.1% Versus Prior Year Period; up 7.1% on a Constant Currency Basis Fourth Quarter 2019 GAAP Diluted EPS from Continuing Operations of $2.28, up 21.9% Versus Prior Year Period Fourth Quarter 2019 Adjusted Diluted EPS from Continuing Operations of $3.28, up 18.4% […]
LOS ALTOS, Calif.–(BUSINESS WIRE)–HeartVista, a pioneer in AI-assisted MRI solutions, announced the formation of its Medical and Scientific Advisory Board, including notable thought leaders from Stanford University and the University of Wisconsin. “The past year was an inflection point for HeartVista, which was full of significant milestones as we received […]
IRVINE, Calif.–(BUSINESS WIRE)–Endologix, Inc. (the “Company”) (NASDAQ: ELGX), a developer and marketer of innovative treatments for aortic disorders, today announced financial results for the fourth quarter and fiscal year ended December 31, 2019. Global revenue in the fourth quarter of 2019 was $35.8 million, a 3.0% increase from $34.7 million […]
Complete reference design saves up to 6 months in development cycle for health-monitoring wearables SAN JOSE, Calif., Feb. 19, 2020 /PRNewswire/ — Blood-oxygen saturation (SpO2), an indicator of oxygen levels in capillary blood, provides a wealth of insights into a person’s well-being. Coupled with other vital signs, SpO2 offers clues into areas […]
U.S. FDA Special Protocol Assessment agreement for a single pivotal Phase 3 clinical trial (PRECISION-AF) of genetically-targeted Gencaro PRECISION-AF clinical trial initiation anticipated fourth quarter of 2020 Trial to evaluate Gencaro as a potential treatment for prevention of atrial fibrillation in a heart failure population for which there are no […]
WESTPORT, Feb. 19, 2020 (GLOBE NEWSWIRE) — Commercialization and install plan ahead of schedule Installations at new centers are driving patient enrollments and clinical data collection BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company developing a proprietary biomedical signal processing platform designed to improve signal […]
TORONTO–(BUSINESS WIRE)–ConaviTM Medical Inc. and Japan Lifeline are pleased to announce that they have received regulatory approval from the Ministry of Health, Labor and Welfare (MHLW) in Japan for the Novasight HybridTM intravascular imaging system. The Novasight Hybrid system is the world’s first clinical system capable of providing both intravascular ultrasound (IVUS) and […]
MARIETTA, Ohio–(BUSINESS WIRE)–ProtoKinetix, Incorporated (www.protokinetix.com) (the “Company” or “ProtoKinetix”) (OTCQB: PKTX) announces the progress of screening PKX-001 for cardiometabolic disorders. “Using isolated cardiac cells, we demonstrated that PKX-001 exerts cardioprotective effects in cells that are exposed to stress induced by nutrient overload or cardiotoxic drugs. Specifically, PKX-001 minimized cardiac cell damage […]
